Study of SHR-1819 for seasonal allergies
Treatments studied
Part of Ear, nose & throat, Immune system & allergy, Lungs & breathing clinical trials.
This trial tests an injection called SHR-1819 for people with seasonal allergic rhinitis (hay fever) that isn't well controlled by standard treatments like nasal sprays or antihistamines. The goal is to see if it helps reduce allergy symptoms during pollen season.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You have been diagnosed with seasonal allergic rhinitis (hay fever) for at least 2 years, with or without itchy, watery eyes.
- You have had poor relief from nasal steroid sprays or other allergy pills during past pollen seasons.
- You have a confirmed allergy to at least one pollen that is in season now, based on a skin test or blood test within the last year.
- You are willing to fill out a daily symptom diary during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new injection called SHR-1819 for people with seasonal allergies who haven't responded well to standard treatments like nasal sprays or antihistamines. It aims to see if it can reduce allergy symptoms.
This study tests a new injection called MG-K10 for people with moderate-to-severe seasonal hay fever that isn't well controlled by standard treatments like nasal sprays or antihistamines. The goal is to see if it can reduce your allergy symptoms over the pollen season.
This study tests an investigational injection called TQH2722 combined with standard allergy therapy for seasonal allergic rhinitis (hay fever). It may help people whose allergy symptoms are not well controlled during pollen season.
This trial tests a new drug called AK139 for people with seasonal allergies (hay fever) that are not well controlled by standard treatments like nasal sprays. It aims to see if the drug can improve symptoms during pollen season.
This study tests a new nasal spray (PG-011) for adults with moderate-to-severe seasonal allergies (hay fever). It compares the spray to a placebo to see if it reduces nasal symptoms like stuffiness, sneezing, and runny nose.
This trial tests whether acupuncture at a specific spot behind the nose can reduce symptoms from seasonal allergies (triggered by things like grass or birch pollen). It may help if your allergy symptoms are moderate to severe and have lasted for a long time.
Hear when a new Seasonal Allergic Rhinitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.